Mabini Colleges
COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name: • Inhibits the movement of
Nifedipine calcium ions across the
membranes of cardiac and
Brand name: arterial muscle cells;
Adalat, Procardia, inhibition of
Afeditab, Nifediac transmembrane calcium
flow results in the
Classification: depression of impulse
• Antianginal formation in a specialized
• Antihypertensive cardiac pacemaker cells, in
• Calcium channel slowing the velocity of
blocker conduction of the cardiac
impulse, in the depression
Dosage: of myocardial contractility,
5g IV stat and in the dilation of
coronary arteries and
arterioles and peripheral
arterioles ; these effects
lead to decreased cardiac
work, decreased cardiac
energy consumption, and
increase delivery of oxygen
to myocardial cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
• For the • Known ➢ Constipation Assessment
management of hypersensitivity ➢ Difficulty of breathing or * History: Allergy to nifedepine,
vasospastic angina, reaction to nifedipine swallowing pregnancy, lactation.
chronic stable ➢ Dizziness or * Physical: Skin lesions, color, edema;
angina and . lightheadedness orientation, reflexes; P, BP, baseline
hypertension ➢ Enlargement of gum tissue ECG, peripheral perfusion,
around teeth auscultation; R, adventitious sounds;
➢ Fast heartbeat liver evaluation, normal GI output;
➢ Flushing (feeling of LFTs
warmth)
➢ Headache Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while drug is being
adjusted to therapeutic dose; the dosage
may be increased more rapidly in
hospitalized patients under close
supervision. Do not exceed 30 mg/dose
increases.
➢ Ensure that patients do not chew
or divide ER tablets
➢ Taper dosage of beta blockers
before nifedepine therapy
➢ Protect drug for light and
moisture.
_______________________________ _____________________________________________
DATE Clinical Instructor